Pericardial disease in the oncology patient

Heart Disease

Volumn 4, Issue 6, 2002, Pages 387-391

  Retter, Avi S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; BLEOMYCIN; CARBOPLATIN; CHLORMETHINE; CISPLATIN; FLUOROURACIL; GOLD; INTERFERON; METHOTREXATE; PHOSPHORUS; PICIBANIL; TETRACYCLINE;

BONE MARROW SUPPRESSION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CONSTRICTIVE PERICARDITIS; HEART DISEASE; HEART TAMPONADE; HEMODYNAMIC MONITORING; HUMAN; INCIDENCE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PATHOPHYSIOLOGY; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PROBLEM SOLVING; PROGNOSIS; REVIEW; THORAX PAIN; TREATMENT INDICATION; TREATMENT PLANNING;

CARDIAC TAMPONADE; HUMANS; INCIDENCE; NEOPLASMS; PERICARDIAL EFFUSION; PERICARDITIS; PROGNOSIS;

EID: 0036866951     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200211000-00008     Document Type: Review

References (36)

1. Scott RW, Garvin CF. Tumors of the heart and pericardium. Am Heart J 1939;17:431-436.
2. Tallman MS, Anderson JW, Schiffer CA, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000;95:90-95.
3. De Botton S, Dombret H, Sanz M, et al. Incidence, clinical features and outcome of All trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood 1998;92:2712-2718.
4. Toren A, Nagler A. Massive pericardial effusion complicating the course of chronic graft versus host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997;20:805-807.
5. Perchinsky MJ, Lichtenstein SV, Tyers GF. Primary cardiac tumors: Forty years' experience with 71 patients. Cancer 1997;79:1809-1815.
6. Remick SC, Hoisington SA, Migliozzi JZ. Epidemic Kaposi's sarcoma presenting with pleuropericarditis. NYS J Med 1992;92:359-365.
7. Just M, Raventos A, Romeu J, et al. Cardiac tamponade and Kaposi's sarcoma. Med Clin Barcelona 1996;102:495-500.
8. Roberts WC, Glancy DL, DeVita VT. Heart in malignant lymphoma. A study of 196 autopsy cases. Am J Cardiol 1968;22:85-91.
9. Petersen CD, Robinson QA, Kurnich JE. Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci 1976;272:161-166.
10. Kline JK. Cardiac lymphatic involvement by metastatic tumor. Cancer 1972;29:799-808.
11. Mann S, Duffy TP. Pericardial tamponade in chronic myelomonocytic leukemia. Chest 1994;106:967-972.
12. Fracp MB, Ingle JN, Giuliani ER, et al. Pericardial effusion in women with breast cancer. Cancer 1987;60:263-269.
13. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine, 5th Ed. Philadelphia: Saunders, 1997.
14. Markiewicz W, Borovic RR, Ecker S. Cardiac tamponade in medical patients: Treatment and prognosis in the echocardiographic era. Am Heart J 1986;111:1138-1146.
15. DeCamp MM, Mentzer SJ, Swanson SJ, et al. Malignant effusive disease of the pleura and pericardium. Chest 1997;112:291s-295s.
16. Nugue O, Millaire A, Porte H, et al. Pericardioscopy in the etiologic diagnosis ofpericardial effusion in 141 consecutive patients. Circulation 1996;94:1635-1642.
17. Caldas C, El-Deiry W. Favorable outcome of cancer patients with cardiac tamponade treated with drainage alone. Proc Ann Meet Am Soc Clin Oncol 1993;12:A1605.
18. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994;272:59-67.
19. Krikorian JL, Hancock EW. Pericardiocentesis. Am J Med 1978;65:808-814.
20. Tsang TS, Seward JB, Barnes Me, et al. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 2000;75:248-253.
21. Maher EA, Shepard FA, and Todd TJR. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996;112:637-643.
22. Shepherd FA, Morgan C, Evans WK, et al. Medical management of malignant pericardial effusions by tetracycline sclerosis. Am J Cardiol 1987;60:1161-1166.
23. Davis S, Sharma SM, Blumberg ED, et al. Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. New Engl J Med 1978;299:1113-1120.
24. Yano T, Yokoyama H, Inoue T, et al. A simple technique to manage pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology 1994;51:507-509.
25. Imamura T, Tamura K, Takenaga M, et al. Intrapericardial OK-432 for the management of malignant pericardial effusion. Cancer 1991;68:259-263.
26. Tomkowski W, Szturmowicz, Fijakowska A, et al. New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer 1997;5:64-66.
27. Moriya T, Takiguchi Y, Tabeta H, et al. Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small cell lung cancer. Br J Cancer 2000;83:858-863.
28. Wilkins HE, Cacioppo JC, Conolly MM, et al. Intrapericardial interferon in the management of malignant pericardial effusion. Chest 1998;114:331-333.
29. Fiocco M, Krasna MJ. The management of malignant pleural and pericardial effusions. Hematol Oncol Clin N Am 1997;11:253-265.
30. Millaire A, Wartz A, deFoot P, et al. Malignant pericardial effusion: Usefulness of pericardioscopy. Am Heart J 1992:1030-1034.
31. Gregory JR, McMurty MJ, Mountain CF. A surgical approach to the treatment of pericardial effusion in cancer patients. Am J Clin Oncol 1985;8:319-323.
32. Mack MJ, Landreneau RJ, Hazelrigg SR, et al. Video thoracoscopic management of benign and malignant pericardial effusions. Chest 1993;103(Suppl):390s-393s.
33. Cham WC, Freiman AH, Carstens PHB. Radiation therapy of cardiac and pericardial metastases. Ther Radiol 1975;114:701-704.
34. Fraser RS, Viloria JB, and Wang NS. Cardiac tamponade as a presentation of extracardiac malignancy. Cancer 1980;45:1697-1704.
35. Yancik R, Reis LG, Yates JW, et al. Breast cancer in aging women. A population-based study of contrasts in stage, surgery and survival. Cancer 1989;63:976-981.
36. King DT, Nieberg RK. The use of cytology to evaluate pericardial effusions. Ann Clin Lab Sci 1979;9:18-23.